In conclusion, we identified four novel mutations in ATP7B gene and found that younger age of onset, the presence of dystonia, and genotype with severe mutations may be predictive of neurological worsening in the neurological WD patients that received chelator therapy. Here, ATP7B is linked to Wilson disease.